BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

39 related articles for article (PubMed ID: 3375336)

  • 1. Effect of novel 7 beta-derivatives of forskolin upon human platelet adenylate cyclase system.
    Seguin E; Ferry N; Hanoune J; Koch M
    Planta Med; 1988 Feb; 54(1):4-6. PubMed ID: 3375336
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibition of Ns-stimulated human platelet adenylate cyclase by forskolin.
    Watanabe Y; Jakobs KH
    Mol Pharmacol; 1986 Mar; 29(3):258-63. PubMed ID: 3005833
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Species differences in alpha 2-adrenergic regulation of platelet adenylate cyclase.
    Slotkin TA; McCook EC; Nemeroff CB; Seidler FJ
    Res Commun Chem Pathol Pharmacol; 1991 Jun; 72(3):259-71. PubMed ID: 1658886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The adenylate cyclase system of human platelets].
    Ferry N; Adnot S; Insel PA; Hanoune J
    Nouv Rev Fr Hematol (1978); 1983; 25(6):343-53. PubMed ID: 6141550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Forskolin-stimulated platelet adenylyl cyclase activity is lower in persons with major depression.
    Menninger JA; Tabakoff B
    Biol Psychiatry; 1997 Jul; 42(1):30-8. PubMed ID: 9193739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Irreversible loss of [3H]forskolin binding sites in human platelets by alpha-haloacetyl analogs of forskolin.
    Laurenza A; Morris D; Seamon KB
    Mol Pharmacol; 1990 Jan; 37(1):69-74. PubMed ID: 2153911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anomalies of the adenylate cyclase system in platelets of the SHR rat].
    Coquil JF; Brunelle G; Meyer P
    Arch Mal Coeur Vaiss; 1988 Jun; 81 Spec No():125-8. PubMed ID: 2847672
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet adenylyl cyclase activity as a trait marker of alcohol dependence. WHO/ISBRA Collaborative Study Investigators. International Society for Biomedical Research on Alcoholism.
    Menninger JA; Barón AE; Conigrave KM; Whitfield JB; Saunders JB; Helander A; Eriksson CJ; Grant B; Hoffman PL; Tabakoff B
    Alcohol Clin Exp Res; 2000 Jun; 24(6):810-21. PubMed ID: 10888069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of thrombocyte adenylate cyclase activity in terminal renal failure.
    Lübbecke F; Matthias FR; Wizemann V
    Thromb Haemost; 1991 Nov; 66(5):623-4. PubMed ID: 1820781
    [No Abstract]   [Full Text] [Related]  

  • 10. Increased platelet adenylate cyclase activity ion diabetic patients with microangiography.
    Janka HU; Standl E; Mehnert H
    Horm Metab Res Suppl; 1981; 11():26-9. PubMed ID: 6172351
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stimulation of adenylate cyclase by water-soluble analogues of forskolin.
    Laurenza A; Khandelwal Y; De Souza NJ; Rupp RH; Metzger H; Seamon KB
    Mol Pharmacol; 1987 Jul; 32(1):133-9. PubMed ID: 3600614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Refractoriness of platelets to prostaglandins after infusion in rabbits.
    Bertelé V; Stemerman M; Schafer A; Adelman B; Smith M; Fuhro R; Salzman E
    J Lab Clin Med; 1985 Nov; 106(5):551-61. PubMed ID: 2997353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of halothane on the cyclic 3',5'-adenosine monophosphate enzyme system in human platelets.
    Walter F; Vulliemoz Y; Verosky Y; Triner L
    Anesth Analg; 1980 Nov; 59(11):856-61. PubMed ID: 6252800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metal and metal-ATP interactions with human platelet adenylate cyclase: effects of alpha adrenergic inhibition.
    Jakobs KH; Saur W; Schultz G
    Mol Pharmacol; 1978 Nov; 14(6):1073-8. PubMed ID: 32476
    [No Abstract]   [Full Text] [Related]  

  • 15. Lithium inhibits adenylate cyclase of human platelets.
    Imandt L; Tijhuis D; Wessels H; Haanen C
    Thromb Haemost; 1981 Apr; 45(2):142-5. PubMed ID: 6266068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of adenylate cyclase activity in lysates of human platelets by the alpha-adrenergic component of epinephrine.
    Jakobs KH; Saur W; Schultz G
    J Cyclic Nucleotide Res; 1976; 2(6):381-92. PubMed ID: 14175
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of adenylate cyclase in human blood platelets by 9-substituted adenine derivatives.
    Harris DN; Asaad MM; Phillips MB; Goldenberg HJ; Antonaccio MJ
    J Cyclic Nucleotide Res; 1979; 5(2):125-34. PubMed ID: 221552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine and clopidogrel (SR 25990C) selectively neutralize ADP inhibition of PGE1-activated platelet adenylate cyclase in rats and rabbits.
    Defreyn G; Gachet C; Savi P; Driot F; Cazenave JP; Maffrand JP
    Thromb Haemost; 1991 Feb; 65(2):186-90. PubMed ID: 2053105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenylate cyclase activation determines the effect of thromboxane synthase inhibitors on platelet aggregation in vitro. Comparison of platelets from responders and nonresponders.
    Gresele P; Blockmans D; Deckmyn H; Vermylen J
    J Pharmacol Exp Ther; 1988 Jul; 246(1):301-7. PubMed ID: 3134542
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Platelet adenylate cyclase activity in alcoholics].
    Tsuchiya F; Sirasaka T; Ikeda H; Hatta Y; Watanabe M; Saito T
    Arukoru Kenkyuto Yakubutsu Ison; 1987 Dec; 22(4):366-72. PubMed ID: 3449035
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.